Skip to main content
logo
Vitrafy Life Sciences Limited (ASX:VFY)
Australia flag Australia · Delayed Price · Currency is AUD
3.830
-0.020 (-0.52%)
Aug 6, 2026, 12:47 PM AEST

Vitrafy Life Sciences Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
29322796---
Market Cap Growth
180.16%136.93%----
Enterprise Value
26820462---
Last Close Price
3.853.011.50---

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
80.1962.0252.62---
PB Ratio
7.145.523.33---
P/TBV Ratio
7.145.523.33---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
73.1455.8933.93---

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.010.010.01-0.95-0.63-1.09
Net Debt / Equity Ratio
-0.63-0.63-1.02-0.69-0.51-0.95
Net Debt / EBITDA Ratio
1.551.552.13-1.98-1.06-1.54
Net Debt / FCF Ratio
1.581.583.32-2.48-1.47-1.09
Asset Turnover
0.100.100.090.280.44-
Quick Ratio
15.3115.3111.470.260.210.26
Current Ratio
23.7723.7711.470.270.210.31
Return on Equity (ROE)
-46.28%-46.28%-1570.08%---
Return on Assets (ROA)
-27.94%-27.94%-41.48%-73.41%-95.96%-
Return on Capital Employed (ROCE)
-40.50%-40.50%-47.40%35.70%50.90%66.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-5.51%-7.13%-34.15%---
FCF Yield
-5.56%-7.19%-9.19%---
Buyback Yield / Dilution
-43.38%-43.39%-1359.98%-4.02%-0.73%-